Cowen And Company, LLC Theravance Biopharma, Inc. Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$16.57 - $21.08 $242,286 - $308,231	-14,622 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$14.89 - $20.16 $217,721 - $294,779	14,622 New	14,622 $260,000
Q3 2020 Nov 03, 2020	SELL	$14.79 - $22.49 $202,090 - $307,303	-13,664 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$20.64 - $30.69 $282,024 - $419,348	13,664 New	13,664 $287,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.